COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake

COVID-19 vaccine hesitancy: Considerations for reluctance and improving vaccine uptake

The emergence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic during the fall of 2019 led to the rapid development of vaccines aimed at curbing viral infection, spread, and its potential eradication. A recent trend is an overall increase in vaccine hesitancy, l...

Full description

Bibliographic Details
Main Authors: Kaushal Parimi, Kyle Gilkeson, Bradley A. Creamer
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
covid-19
sars-cov-2
vaccine
hesitancy
pandemic
Online Access:http://dx.doi.org/10.1080/21645515.2022.2062972

Internet

http://dx.doi.org/10.1080/21645515.2022.2062972

Similar Items